| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Cancer Research, Vol 2, Issue 5 799-803, Copyright © 1996 by American Association for Cancer Research
ARTICLES |
W Zhang, MA Piatyszek, T Kobayashi, E Estey, M Andreeff, AB Deisseroth, WE Wright and JW Shay
Departments of Neuro-Oncology and Hematology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
The terminal regions of human chromosomes, the telomeres, shorten with each cell division in most normal somatic cells. Telomerase, a ribonucleoprotein that synthesizes telomeric DNA onto chromosomal ends, is activated in germline cells and almost all tumor cells. Telomerase activity maintains the stability of telomere length, resulting in indefinite cellular proliferation (immortality). In the present study, telomerase activity was analyzed in leukemic mononuclear blood cells obtained from 56 patients with acute myelogenous leukemia (AML) with known cytogenetic alterations. Heterogenous levels of telomerase activity were observed and generally correlated with cytogenetic status. Patients with 11q abnormalities and -5/-7 (unfavorable cytogenetics) tended to have high telomerase activity compared with cells obtained from AML patients with other types of cytogenetics. Additional studies with a larger cohort of patients will determine whether these differences are statistically significant. Chemotherapy agents that result in differentiation of leukemic cells also resulted in inhibition of telomerase activity. Knowledge of telomerase activity in patients with AML, before and throughout therapy, may have clinical utility for following disease progression and may predict early cancer relapse.
This article has been cited by other articles:
|
|
 |
|
  S. H. Ghaffari, N. Shayan-Asl, A. H. Jamialahmadi, K. Alimoghaddam, and A. Ghavamzadeh Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival Ann. Onc., June 20, 2008; (2008) mdn394v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bagheri, M. Nosrati, S. Li, S. Fong, S. Torabian, J. Rangel, D. H. Moore, S. Federman, R. R. LaPosa, F. L. Baehner, et al. Genes and pathways downstream of telomerase in melanoma metastasis PNAS, July 25, 2006; 103(30): 11306 - 11311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nosrati, S. Li, S. Bagheri, D. Ginzinger, E. H. Blackburn, R. J. Debs, and M. Kashani-Sabet Antitumor Activity of Systemically Delivered Ribozymes Targeting Murine Telomerase RNA Clin. Cancer Res., August 1, 2004; 10(15): 4983 - 4990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-S. Cong, W. E. Wright, and J. W. Shay Human Telomerase and Its Regulation Microbiol. Mol. Biol. Rev., September 1, 2002; 66(3): 407 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. S. J. Elenitoba-Johnson Complex Regulation of Telomerase Activity : Implications for Cancer Therapy Am. J. Pathol., August 1, 2001; 159(2): 405 - 410. [Full Text]
|
|
|
|
|
|
S. Y. Rha, E. Izbicka, R. Lawrence, K. Davidson, D. Sun, M. P. Moyer, G. D. Roodman, L. Hurley, and D. Von Hoff Effect of Telomere and Telomerase Interactive Agents on Human Tumor and Normal Cell Lines Clin. Cancer Res., March 1, 2000; 6(3): 987 - 993. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Engelhardt, K. Mackenzie, P. Drullinsky, R. T. Silver, and M. A. S. Moore Telomerase Activity and Telomere Length in Acute and Chronic Leukemia, Pre- and Post-ex Vivo Culture Cancer Res., February 1, 2000; 60(3): 610 - 617. [Abstract] [Full Text]
|
|
|
|
|
|
J. S. Dome, S. Chung, T. Bergemann, C. B. Umbricht, M. Saji, L. A. Carey, P. E. Grundy, E. J. Perlman, N. E. Breslow, and S. Sukumar High Telomerase Reverse Transcriptase (hTERT) Messenger RNA Level Correlates with Tumor Recurrence in Patients with Favorable Histology Wilms' Tumor Cancer Res., September 1, 1999; 59(17): 4301 - 4307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Frenck Jr., E. H. Blackburn, and K. M. Shannon The rate of telomere sequence loss in human leukocytes varies with age PNAS, May 12, 1998; 95(10): 5607 - 5610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Fitzgerald, T. D. McKnight, and D. E. Shippen Characterization and developmental patterns of telomerase expression in plants PNAS, December 10, 1996; 93(25): 14422 - 14427. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
